1998
Socially desirable response tendency as a correlate of accuracy of self‐reported HIV serostatus for HIV seropositive injection drug users
Latkin C, Vlahov D. Socially desirable response tendency as a correlate of accuracy of self‐reported HIV serostatus for HIV seropositive injection drug users. Addiction 1998, 93: 1191-1197. PMID: 9813900, DOI: 10.1046/j.1360-0443.1998.93811917.x.Peer-Reviewed Original ResearchConceptsSelf-reported HIV serostatusSocial desirabilityInjection drug usersCorrelates of accuracyDesirable response tendenciesHIV serostatusDrug usersResponse tendenciesDesirable respondingHIV-seronegative participantsALIVE studyPredictive validityHIV-seropositive injection drug usersActive injection drug usersLongitudinal studySeropositive injection drug usersPositive predictive value 97Higher scoresHIV-seropositive participantsHIV prevention studyQuestionable validityNegative predictive valueParticipantsSeronegative participantsSeropositive participants
1996
Existence and Failure of T-Cell Homeostasis Prior to AIDS Onset in HIV-Infected Injection Drug Users
Galai N, Margolick J, Astemborski J, Vlahov D. Existence and Failure of T-Cell Homeostasis Prior to AIDS Onset in HIV-Infected Injection Drug Users. Clinical Immunology 1996, 79: 134-141. PMID: 8620619, DOI: 10.1006/clin.1996.0060.Peer-Reviewed Original ResearchConceptsInjection drug usersTotal T cellsT cell homeostasisT cellsHIV infectionAIDS onsetAIDS diagnosisHomosexual menDrug usersCurrent injection drug useSeropositive injection drug usersInjection drug useT cell levelsImportant prognostic valueALIVE studyClinic visitsPrognostic valueRisk groupsT lymphocytesAIDS casesLate failureDrug useHIVAIDSMonths
1995
Factors Associated with Initiation of Zidovudine in a Cohort of Injection Drug Users
Solomon L, Vlahov D, Astemborski J, Galai N, Graham N, Nelson K. Factors Associated with Initiation of Zidovudine in a Cohort of Injection Drug Users. Journal Of Drug Issues 1995, 25: 225-233. DOI: 10.1177/002204269502500115.Peer-Reviewed Original Research
1994
Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users.
Caiaffa W, Vlahov D, Graham N, Astemborski J, Solomon L, Nelson K, Muñoz A. Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users. American Journal Of Respiratory And Critical Care Medicine 1994, 150: 1493-1498. PMID: 7952605, DOI: 10.1164/ajrccm.150.6.7952605.Peer-Reviewed Original ResearchMeSH KeywordsAdultAIDS-Related Opportunistic InfectionsCocaineCohort StudiesCrack CocaineFemaleHIV SeronegativityHIV SeropositivityHIV-1HumansImmunocompromised HostIncidenceMaleMarijuana SmokingOdds RatioPneumoniaPneumonia, PneumocystisRisk FactorsSmokingSubstance Abuse, IntravenousSubstance-Related DisordersConceptsInjection drug usersPneumocystis carinii pneumoniaHIV-seropositive injection drug usersBacterial pneumoniaOdds ratioCarinii pneumoniaCigarette smokingFirst episodeDrug usersIllicit drugsSeropositive injection drug usersCD4 lymphocyte countHIV-seronegative subjectsMedical record reviewHuman immunodeficiency virusCells/Conditional logistic regressionSeronegative subjectsCohort studyLymphocyte countRecord reviewImmunodeficiency virusControl subjectsRisk factorsUnivariate analysisDrug‐related behavior change for HIV transmission among American injection drug users
CELENTANO D, MUÑOZ A, CORN S, NELSON K, VLAHOV D. Drug‐related behavior change for HIV transmission among American injection drug users. Addiction 1994, 89: 1309-1317. PMID: 7804092, DOI: 10.1111/j.1360-0443.1994.tb03310.x.Peer-Reviewed Original ResearchConceptsInjection drug usersSeropositive injection drug usersRisk behaviorsHIV infectionDrug usersActive injection drug usersDrug-related risk behaviorsHuman immunodeficiency virus (HIV) transmissionHigh-risk drug-related behaviorsSemi-annual visitsMultiple logistic regressionBehavior changeGreater risk reductionDrug-related behaviorsLow-risk behaviorsSeropositive participantsHIV serostatusHIV transmissionLongitudinal cohortVaccine developmentPrevention programsLogistic regressionAIDS epidemicVirus transmissionBehavior maintenance